Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability

References

• ZhaoYXinTYeTYangXPanWSolid dispersion in the development of a nimodipine delayed-release tablet formulationAsian J Pharm Sci2014913541
   Google Scholar
• FuQSunJAiXNimodipine nanocrystals for oral bioavailability improvement: role of mesenteric lymph transport in the oral absorptionInt J Pharm2013448129029723384726
   PubMedGoogle Scholar
• MorenoLCda Silva OliveiraGZCavalcantiIMSantos-MagalhãesNSRolimHMde FreitasRMDevelopment and evaluation of liposomal formulation containing nimodipine on anxiolytic activity in micePharmacol Biochem Behav2014116646824201051
   PubMedGoogle Scholar
• HuFQZhangYduYZYuanHFqHYzDNimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous systemInt J Pharm20083481–214615217889464
   PubMedGoogle Scholar
• GuanTMiaoYXuLInjectable nimodipine-loaded nanoliposomes: preparation, lyophilization and characteristicsInt J Pharm20114101–218018721414393
   PubMedGoogle Scholar
• GargNKTyagiRKSinghBNanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1Int J Pharm20164991–230132026768725
   PubMed Web of Science ®Google Scholar
• GuadaMLasa-SaracíbarBLanaHDios-ViéitezMCBlanco-PrietoMJLipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studiesInt J Pharm20165001–215416126794875
   PubMedGoogle Scholar
• BeloquiASolinísMÁRodríguez-GascónAAlmeidaAJPréatVNanostructured lipid carriers: Promising drug delivery systems for future clinicsNanomedicine201612114316126410277
   PubMed Web of Science ®Google Scholar
• TapeinosCBattagliniMCiofaniGAdvances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseasesJ Control Release201726430633228844756
   PubMed Web of Science ®Google Scholar
• Sánchez-LópezEEspinaMDoktorovovaSSoutoEBGarcíaMLLipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part I – Barriers and determining factors in ocular deliveryEur J Pharm Biopharm2017110707527789358
   PubMed Web of Science ®Google Scholar
• ParkSJGarciaCVShinGHKimJTImprovement of curcuminoid bioaccessibility from turmeric by a nanostructured lipid carrier systemFood Chem2018251515729426423
   PubMed Web of Science ®Google Scholar
• Ali KhanAMudassirJMohtarNDarwisYAdvanced drug delivery to the lymphatic system: lipid-based nanoformulationsInt J Nanomedicine201382733274423926431
   PubMed Web of Science ®Google Scholar
• ChalikwarSSBelgamwarVSTaleleVRSuranaSJPatilMUFormulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport systemColloids Surf B Biointerfaces20129710911622609590
   PubMed Web of Science ®Google Scholar
• BegSSharmaGThankiKJainSKatareOPSinghBPositively charged self-nanoemulsifying oily formulations of olmesartan medoxomil: Systematic development, in vitro, ex vivo and in vivo evaluationInt J Pharm20154931–246648226211900
   PubMedGoogle Scholar
• KaithwasVDoraCPKushwahVJainSNanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailabilityColloids Surf B Biointerfaces2017154102028284054
   PubMed Web of Science ®Google Scholar
• LiuKSunJWangYHeYGaoKHeZPreparation and characterization of 10-hydroxycamptothecin loaded nanostructured lipid carriersDrug Dev Ind Pharm200834546547118473227
   PubMed Web of Science ®Google Scholar
• EspositoEDrechslerMCortesiRNastruzziCEncapsulation of can-nabinoid drugs in nanostructured lipid carriersEur J Pharm Biopharm2016102879126952905
   PubMed Web of Science ®Google Scholar
• ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm20103941–217918520471464
   PubMed Web of Science ®Google Scholar
• WolfMKlangVHalperMMonoacyl-phospatidylcholine nanostructured lipid carriers: Influence of lipid and surfactant content on in vitro skin permeation of flufenamic acid and fluconazoleJ Drug Deliv Sci Technol201741419430
   Google Scholar
• OkonogiSRiangjanapateePPhysicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administrationInt J Pharm2015478272673525479097
   PubMed Web of Science ®Google Scholar
• YostawonkulJSurassmoSIemprideeTSurface modification of nanostructure lipid carrier (NLC) by oleoyl-quaternized-chitosan as a mucoadhesive nanocarrierColloids Surf B Biointerfaces201714930131127780087
   PubMed Web of Science ®Google Scholar
• LiuXWangSChaiLA two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniquesInt J Pharm20144611–252953924374219
   PubMedGoogle Scholar
• NnamaniPOHansenSWindbergsMLehrCMDevelopment of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical applicationInt J Pharm20144771–220821725290810
   PubMed Web of Science ®Google Scholar
• KumbharDDPokharkarVBEngineering of a nanostructured lipid carrier for the poorly water-soluble drug, bicalutamide: Physicochemical investigationsColloids Surf A Physicochem Eng Asp201341613242
   Google Scholar
• HeJHanYXuGPreparation and evaluation of celecoxib nanosuspensions for bioavailability enhancementRSC Adv20177221305313064
   Web of Science ®Google Scholar
• LuoYChenDRenLZhaoXQinJSolid lipid nanoparticles for enhancing vinpocetine’s oral bioavailabilityJ Control Release20061141535916828192
   PubMed Web of Science ®Google Scholar
• SinghBSinghRBandyopadhyaySKapilRGargBOptimized nanoemulsifying systems with enhanced bioavailability of carvedilolColloids Surf B Biointerfaces2013101146547423010056
   PubMedGoogle Scholar
• MorenoLRolimHMLFreitasRMSantos-MagalhãesNSAntidepressant-like activity of liposomal formulation containing nimodipine treatment in the tail suspension test, forced swim test and MAOB activity in miceBrain Res2016164623524027270234
   PubMedGoogle Scholar
• PokharkarVPatil-GadheAKaurGPhysicochemical and pharmacokinetic evaluation of rosuvastatin loaded nanostructured lipid carriers: influence of long- and medium-chain fatty acid mixtureJ Pharm Invest2018484465476
   Google Scholar
• SunCWangJLiuJQiuLZhangWZhangLLiquid proliposomes of nimodipine drug delivery system: preparation, characterization, and pharmacokineticsAAPS Pharm Sci Tech2013141332338
   PubMed Web of Science ®Google Scholar
• ZhangHChenWZhaoZLyophilized Nanosuspensions for Oral Bioavailability Improvement of Insoluble Drugs: Preparation, Characterization, and Pharmacokinetic StudiesJ Pharm Innov2017123271280
   Web of Science ®Google Scholar
• FathiHAAllamAElsabahyMFetihGEl-BadryMNanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatinColloids Surf B Biointerfaces201816223624529197789
   PubMed Web of Science ®Google Scholar
• GargNKSharmaGSinghBQuality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s)Int J Pharm20175171–241343127956192
   PubMed Web of Science ®Google Scholar
• JacobsCKayserOMüllerRHNanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepideInt J Pharm2000196216116410699709
   PubMed Web of Science ®Google Scholar
• NevesARQueirozJFReisSBrain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein EJ Nanobiotechnol20161427
   PubMed Web of Science ®Google Scholar
• FlannerHMooreJWMathematical comparison of curves with an emphasis on dissolution profilesPharm Technol19962066474
   Google Scholar
• FangGTangBChaoYCysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic StudyMol Pharm20151272384239525974386
   PubMedGoogle Scholar
• CavalliRCaputoOCarlottiMETrottaMScarnecchiaCGascoMRSterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticlesInt J Pharm199714814754
   Web of Science ®Google Scholar
• LeeHJKimJYParkSHRheeYSParkCWParkESControlled-release oral dosage forms containing nimodipine solid dispersion and hydrophilic carriersJ Drug Deliv Sci Technol2017372837
   Web of Science ®Google Scholar
• Seyed YagoubiAShahidiFMohebbiMVaridiMGolmohammadzadehSPreparation, characterization and evaluation of physicochemical properties of phycocyanin-loaded solid lipid nanoparticles and nanostructured lipid carriersJ Food Meas Characterization2018121378385
   Google Scholar
• ZhangZBuHGaoZHuangYGaoFLiYThe characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in ratsInt J Pharm20103941–214715320435111
   PubMedGoogle Scholar
• DengCJiaMWeiGInducing Optimal Antitumor Immune Response through Coadministering iRGD with Pirarubicin Loaded Nanostructured Lipid Carriers for Breast Cancer TherapyMol Pharm201714129630927936775
   PubMedGoogle Scholar
• CourantTBayonEReynaud-DougierHLTailoring nano-structured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studiesBiomaterials2017136294228511142
   PubMedGoogle Scholar
• YangSZhuJLuYLiangBYangCBody distribution of camptothecin solid lipid nanoparticles after oral administrationPharm Res199916575175710350020
   PubMed Web of Science ®Google Scholar
• LiJFuQLiuXLiMWangYFormulation of nimodipine nanocrystals for oral administrationArch Pharm Res201639220221226584914
   PubMedGoogle Scholar